compensation: Eligible participants in the study will be compensated
employment type: employee's choice
QR Code Link to This Post
It has been 14 years since the last medication hit the market for Alzheimer's Disease (AD). The condition continues to be a concern as cases steadily grow every year. Local physicians recognize the need for new care options and are working with adults who have mild memory loss or early AD to help evaluate an investigational treatment. If you or a loved one has mild memory loss or early AD, a clinical research study may be an option. Find out more today.
Qualified Participants must:
Qualified Participants may:
Ref #: 880-PRI